Catalyst Pharmaceuticals, Inc. ( CPRX) - Key Metrics
Stock symbol CPRX is outdated, potentially delisted? Maybe it is available on other exchange?
CPRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $1.22 | $0.52 | $0.49 | $0.49 |
| 2025Q4 | $1.25 | $0.43 | $0.37 | $0.37 |
| 2025Q3 | $1.21 | $0.43 | $0.26 | $0.26 |
| 2025Q2 | $1.20 | $0.43 | $0.58 | $0.58 |
| 2025Q1 | $1.16 | $0.47 | $0.49 | $0.49 |
CPRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | 11.90 |
| 2025Q4 | 0% | 13.89 |
| 2025Q3 | 0% | 11.45 |
| 2025Q2 | 0% | 12.62 |
| 2025Q1 | 0% | 12.90 |
CPRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.97% | 0% |
| 2025Q4 | 1.57% | 0% |
| 2025Q3 | 1.34% | 0% |
| 2025Q2 | 2.69% | 0% |
| 2025Q1 | 2.04% | 0% |
CPRX
Price: $31.49
52 week price:
Earnings Per Share: 1.73 USD
P/E Ratio: 18.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -4.3 millionMarket Capitalization: 3.9 billion